Grass City 20% OFF

MariMed Inc. (OTCQB:MRMD), presents its strategy to capitalize on the design, development, operation, funding, and optimization of medical cannabis cultivation, production, and dispensary facilities to investors at the 2017 Marcum MicroCap Conference on June 15. The Marcum conference is a highlight on the annual investment community calendar in New York City.

Mr. Robert Fireman, CEO of MariMed Advisors, will share the details behind MariMed’s year-over-year revenue growth, discuss the growing cannabis industry and its multi-billion opportunity, as well as review recent highlights. The presentation will take place at 4:00 PM. To arrange a meeting with management, please contact Robert Haag at or 1-866-976-4784.

The Marcum MicroCap Conference ( is a nationally recognized forum for publicly traded companies with less than $500 million in market capitalization to network with fund managers and high net worth investors who focus on small cap equities. More than 2000 investors and other participants from every segment of the microcap marketplace attend each year, including venture and lower middle-market private equity investors, institutional investors, directors, investment bankers, and buy- and sell-side analysts, as well as senior executive teams from presenting companies and service providers to the microcap marketplace.

The conference is presented by Marcum LLP, a top national accounting and advisory firm registered with the Public Company Accounting Oversight Board (PCAOB). Marcum’s Assurance Division provides the most up-to-date service and guidance on SEC accounting and reporting issues. Services include Financial Statement Audits in accordance with PCAOB standards; Tax Compliance and Advisory Services; Due Diligence; Agreed-Upon Procedures and Other Attest Work; Internal Audit Services; Sarbanes-Oxley Section 404 Compliance Services and Software; Technical Accounting Assistance; and IPO Assistance. For more information, visit

About MariMed (formerly Worlds Online):

MariMed Inc., is an industry leader in the design, development, operation, funding, and optimization of medical cannabis cultivation, production, and dispensary facilities. MariMed’s team has developed five state-of-the-art, regulatory-compliant facilities in three states, with six additional facilities currently under development in two other states. These facilities are models of excellence in horticultural principals, cannabis production, product development, and dispensary operations. MariMed is on the forefront of precision dosed products for the treatment of specific medical conditions. MariMed branded products are being distributed in three states with distribution being finalized in six additional states. For additional information about MariMed, visit

Contact:MariMed Business DevelopmentJon Levine, CFO, MariMed Advisors844-244-0200Investor Relations+1-866-976-4784Media RelationsJulie Shepherd, Accentuate PR847-275-3643

<img src=”” alt=”” width=”1″ height=”1″/>

Stock Symbols